Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
57 studies found for:    "Prader-Willi syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Oxytocin Trial in Prader-Willi Syndrome
Condition: Prader Willi Syndrome
Interventions: Drug: Intranasal oxytocin;   Other: Placebo
2 Completed Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: DCCR;   Drug: Placebo
3 Completed Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Norditropin SimpleXx
4 Recruiting Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: RM-493;   Drug: Placebo
5 Unknown  Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell
Condition: Prader-Willi Syndrome
Intervention: Drug: Recombinant Somatropin
6 Unknown  Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Device: Deep Brain Stimulation
7 Terminated
Has Results
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
Condition: Prader-Willi Syndrome
Interventions: Drug: Octreotide;   Drug: Placebo
8 Recruiting Register of Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Other: Data collection
9 Unknown  Growth Hormone Use in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Nutropin AQ
10 Recruiting Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: Oxytocin continuous;   Drug: Placebo;   Drug: Placebo continuous;   Drug: Oxytocin
11 Completed Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
Condition: Prader-Willi Syndrome
Intervention:
12 Unknown  Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Exenatide
13 Not yet recruiting Cannabidiol Oral Solution for The Treatment of Subjects With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: Cannabidiol;   Drug: Placebo
14 Completed Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks
Condition: Prader-Willi Syndrome
Interventions: Drug: Topiramate;   Drug: Placebo Comparator
15 Recruiting Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: Eutropin;   Drug: Genotropin
16 Completed
Has Results
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Exenatide
17 Unknown  Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Condition: Prader-willi Syndrome
Interventions: Drug: rimonabant;   Drug: placebo
18 Completed Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Intervention:
19 Completed Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Intervention:
20 Completed Hypoglycemia in Prader-Willi Syndrome
Conditions: Prader Willi Syndrome;   Hypoglycemia
Intervention: Other: Infants with Prader-Willi Syndrome

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.